Human Leucocyte Antigen–Matching Can Improve Long Term Outcome of Renal Allografts from Donors Older Than 75 Years
Transplantation Proceedings · 2023
DOI: 10.1016/j.transproceed.2022.12.014 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Transplantation Proceedings, 2023. Verfasst von Martina Koch und 10 weiteren Autor:innen. Beteiligte Einrichtung: General-, Visceral- and Transplantation Surgery, University Medical Center, Mainz, Germany; Hepatobiliary Surgery and Transplantation, University Med…. Hauptthemen laut MEDLINE: Kidney Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Renal transplantation is the therapy of choice for kidney failure. The Eurotransplant Senior Program (ESP) has been established to allocate kidneys ≥65 years to recipients of the same age group considered a regional allocation with short cold ischemia (CIT) but not human-leukocyte-antigen (HLA)-matching. The acceptance of organs aged ≥75 years is also still controversial within the ESP. METHODS: In a multicenter approach, 179 kidney grafts ≥75 years (mean donor age 78 years) that were transplanted in 174 patients in 5 German transplant centers were analyzed. The primary focus of the analysis was long-term outcome of the grafts and the impact of CIT, HLA matching, and recipient related risk factors. RESULTS: The mean graft survival was 59 months (median 67 months) with a mean donor age of 78.3 ± 2.9 years. Grafts with 0 to 3 HLA-mismatches had a significantly better overall graft survival compared to grafts with ≥4 mismatches (69 months vs 54 months; P = .008). The mean CIT was short (11.9 ± 5.3 hours) and had no impact on graft survival. CONCLUSION: Recipients receiving a kidney graft from donors aged ≥75 years can benefit from nearly 5 years of survival with a functioning graft. Even minimal HLA matching may improve long term allograft survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- General-, Visceral- and Transplantation Surgery, University Medical Center, Mainz, Germany; Hepatobiliary Surgery and Transplantation, University Medical Center Hamburg-Eppendorf, Germany. Electronic address: Martina.Ko…
- Department of Nephrology, University Medical Center Regensburg, Germany.
- Department of Nephrology, University Medical Center Würzburg, Germany.
- Department of Medicine, Section Nephrology; University Medical Center, Mainz, Germany.
- Institute of Medical Biostatistics, Epidemiology and Informatics; University Medical Center, Mainz, Germany.
- Hepatobiliary Surgery and Transplantation, University Medical Center Hamburg-Eppendorf, Germany; Clinic of Hepato-pancreatico-biliary Surgery and The Transplantation Center First Affiliated Hospital, School of Life Scie…
Zitieren
APA
Koch, M., Zecher, D., Lopau, K., Weinmann-Menke, J., Schulze, A., Nashan, B., Wenzel, U., Banas, B., Zeier, M., Thaiss, F., & Sommerer, C. (2023). Human Leucocyte Antigen–Matching Can Improve Long Term Outcome of Renal Allografts from Donors Older Than 75 Years. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2022.12.014
Vancouver
Koch M, Zecher D, Lopau K, Weinmann-Menke J, Schulze A, Nashan B, et al. Human Leucocyte Antigen–Matching Can Improve Long Term Outcome of Renal Allografts from Donors Older Than 75 Years. Transplantation Proceedings. 2023. doi:10.1016/j.transproceed.2022.12.014
BibTeX
@article{Koch2023,
author = {Koch, Martina and Zecher, Daniel and Lopau, Kai and Weinmann-Menke, Julia and Schulze, Alicia and Nashan, Björn and Wenzel, Ulrich and Banas, Bernhard and Zeier, Martin and Thaiss, Friedrich and Sommerer, Claudia},
title = {Human Leucocyte Antigen–Matching Can Improve Long Term Outcome of Renal Allografts from Donors Older Than 75 Years},
journal = {Transplantation Proceedings},
year = {2023},
doi = {10.1016/j.transproceed.2022.12.014}
}
EUVIMED